시장보고서
상품코드
1577505

세계의 의료 정보 시장

Medical Information

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 270 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 의료 정보 시장 2030년까지 41억 달러에 달할 것으로 전망

2023년 28억 달러로 추정되는 세계 의료 정보 시장은 2023년부터 2030년까지 연평균 5.4% 성장하여 2030년에는 41억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 인하우스 서비스 부문은 CAGR 5.0%를 기록하여 분석 기간 종료 시점에 23억 달러에 달할 것으로 예상됩니다. 아웃소싱 서비스 부문은 분석 기간 동안 CAGR 5.9%의 성장률을 기록할 것으로 예상됩니다.

미국 시장 7억 6,600만 달러로 추정, 중국은 CAGR 8.6%로 성장 전망

미국의 의료 정보 시장은 2023년 7억 6,660만 달러에 달할 것으로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 8억 4,390만 달러의 시장 규모에 도달할 것으로 예상되며, 2023-2030년 분석 기간 동안 8.6%의 CAGR을 기록할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 2.2%와 5.5%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 연평균 3.3%의 성장률을 보일 것으로 예상됩니다.

세계 의료 정보 시장 - 주요 동향 및 촉진요인 요약

의료 정보는 어떻게 진화해 왔을까?

지난 수십 년 동안 의료 정보는 서류 캐비넷에 보관된 종이 기반 기록에서 전 세계 어디에서나 실시간으로 접근할 수 있는 첨단 전자 의료 기록(EHR)으로 진화하며 급격한 변화를 겪어왔습니다. 과거에는 의료 서비스 제공자 간의 환자 데이터 공유는 종종 시간이 오래 걸리고 비효율적이며, 단편적인 진료로 이어지곤 했습니다. 그러나 디지털 솔루션의 등장으로 의료 정보는 더욱 간소화되고 접근성이 향상되었으며, 전반적인 의료 서비스의 질이 향상되었습니다. 이러한 변화는 더 나은 환자 결과, 데이터 보안, 규제 준수에 대한 요구가 높아지면서 더욱 가속화되고 있습니다. 또한, 의료 제공자와 환자 모두 모바일 헬스(mHealth) 애플리케이션, 웨어러블, 원격의료를 도입하여 원격으로 건강 상태를 모니터링하고 관리하고 있습니다. 이러한 발전으로 인해 보다 개인화된 치료가 가능해졌고, 데이터는 환자 개개인의 필요에 맞는 치료를 제공하는 데 중요한 역할을 하고 있습니다. 이러한 발전은 환자와 의료 서비스 제공자 간의 격차를 해소하는 데 있어 기술이 얼마나 중요한 역할을 하고 있는지를 잘 보여줍니다.

오늘날 의료 정보가 직면한 윤리와 프라이버시 문제는 무엇일까?

디지털 의료 정보의 장점에도 불구하고, 데이터 프라이버시 및 보안에 대한 심각한 우려가 계속되고 있습니다. 사이버 공격과 데이터 유출이 증가함에 따라 환자와 의료 서비스 제공자 모두 민감한 의료 정보가 악용될 가능성에 노출되어 있습니다. 가장 시급한 윤리적 문제 중 하나는 데이터 공유와 환자 기밀 유지의 균형을 맞추는 것입니다. 공동 진료와 공동 연구를 촉진하기 위해 더 많은 데이터가 네트워크에서 공유됨에 따라 환자의 동의가 적절하게 얻어지고 환자의 데이터가 안전하게 유지되도록 보장해야 할 필요성이 커지고 있습니다. 미국의 의료보험 상호운용성 및 책임에 관한 법률(HIPAA)이나 유럽의 일반 데이터 보호 규정(GDPR)과 같은 규제 프레임워크는 의료 데이터 처리 방식에 대한 엄격한 가이드라인을 제시하고 있습니다. 그러나 이러한 규제는 지역마다 크게 다르기 때문에 의료 정보 보안에 대한 세계 표준을 만드는 것은 쉽지 않습니다. 또한, 인공지능(AI)과 머신러닝 알고리즘을 사용하여 의료 데이터를 분석하는 것은 의사결정의 잠재적 편향성과 이러한 시스템의 투명성에 대한 논쟁을 불러일으키고 있습니다. 기술이 계속 발전하는 가운데, 이러한 윤리 및 프라이버시 문제를 해결하는 것은 의료 시스템에 대한 신뢰를 유지하는 데 있어 가장 중요한 문제입니다.

의료 정보 접근성을 변화시키는 데 있어 기술의 역할은 무엇인가?

기술은 의료 정보에 대한 접근, 공유 및 활용 방식을 변화시키는 최전선에 있습니다. 빅데이터 분석의 부상으로 의료 서비스 제공자는 방대한 양의 의료 데이터를 분석하여 패턴을 감지하고 건강 상태를 예측할 수 있게 되었습니다. 클라우드 컴퓨팅의 통합으로 의료 기관은 의료 기록을 안전하게 보관하고 액세스 할 수 있으며 동시에 온프레미스 스토리지 시스템과 관련된 비용을 절감할 수 있게 되었습니다. 또한 원격의료 플랫폼과 환자 포털을 통해 환자들은 자신의 건강을 더 잘 통제할 수 있게 되었으며, 의료 기록에 접근하고, 의료진과 소통하고, 심지어 온라인 예약까지 할 수 있게 되었습니다. 진단 도구에 AI를 활용하면 진단의 정확성과 속도를 높이고 인적 오류의 가능성을 줄여 의료 서비스 제공자가 더 많은 정보에 입각한 판단을 내릴 수 있게 됩니다. 스마트워치, 피트니스 트래커와 같은 웨어러블 기기는 환자의 활력 징후를 지속적으로 모니터링하여 건강 문제를 조기에 발견하고 보다 적시에 개입할 수 있도록 돕습니다. 헬스케어 시스템의 디지털화가 진행됨에 따라, 기술은 의료 정보의 접근성과 품질을 향상시키는 데 있어 더욱 큰 역할을 할 것으로 보입니다.

의료 정보 시장의 성장 촉진요인은?

의료 정보 시장의 성장에는 몇 가지 요인이 있는데, 그 중 대부분은 기술 발전과 소비자 행동의 변화와 직결되어 있습니다. 첫째, 전 세계 의료 시설의 EHR 시스템 도입이 증가함에 따라 신뢰성과 확장성이 뛰어난 디지털 솔루션에 대한 수요가 증가하고 있습니다. 의료 서비스 제공자들이 여러 플랫폼과 의료기관에서 환자 정보를 원활하게 공유할 수 있는 방법을 찾고 있기 때문에 서로 다른 시스템 간의 상호운용성에 대한 필요성도 중요한 촉진제 역할을 하고 있습니다. 또한, 만성질환의 확산으로 인해 보다 빈번하고 종합적인 환자 모니터링이 필요해지면서 원격 모니터링 기기 및 모바일 헬스 애플리케이션에 대한 수요가 급증하고 있습니다. 소비자 행동도 변화하고 있으며, 환자들은 점점 더 편리하고 디지털 우선적인 의료 경험을 기대하는 경향이 있습니다. 이는 원격의료 서비스의 급격한 성장을 촉진했습니다. 정부의 디지털 헬스 추진 노력과 헬스케어 분야에서 데이터 기반 의사결정의 필요성도 시장 확대에 기여하고 있습니다. 마지막으로, AI와 머신러닝을 의료 정보 시스템에 통합하여 예측 분석과 진단 정확도를 높이고 환자 데이터를 보다 효과적으로 관리할 수 있는 최첨단 도구를 의료 서비스 제공자에게 제공함으로써 시장 성장을 더욱 촉진하고 있습니다.

조사 대상 기업 예시(36개사)

  • Accenture Plc
  • Cognizant Technology Solutions U.S. Corporation
  • Eversana
  • Groupe ProductLife S.A.S.
  • Infosys Ltd.
  • Inizio Engage
  • Intellectsoft
  • IQVIA, Inc.
  • McKesson Corporation
  • Med Communications

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 24.10.29

Global Medical Information Market to Reach US$4.1 Billion by 2030

The global market for Medical Information estimated at US$2.8 Billion in the year 2023, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. In-House Services, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Contract Outsourcing Services segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$766.6 Million While China is Forecast to Grow at 8.6% CAGR

The Medical Information market in the U.S. is estimated at US$766.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$843.9 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Medical Information Market - Key Trends and Drivers Summarized

How Has Medical Information Evolved Over Time?

Medical information has undergone a dramatic transformation over the last few decades, evolving from paper-based records maintained in filing cabinets to sophisticated electronic health records (EHRs) that can be accessed in real-time from anywhere in the world. In the past, the sharing of patient data between healthcare providers was often slow and inefficient, leading to fragmented care. However, with the advent of digital solutions, medical information is now more streamlined and accessible, enhancing the overall quality of healthcare. This shift has been driven by the increasing demand for better patient outcomes, data security, and regulatory compliance. In addition, healthcare providers and patients alike are now embracing mobile health (mHealth) applications, wearables, and telemedicine to monitor and manage health conditions remotely. These advancements have resulted in more personalized care, with data playing a crucial role in tailoring treatments to individual patients' needs, thus moving the medical landscape toward more proactive and preventive care approaches. This evolution highlights how crucial technology has become in bridging the gap between patients and healthcare providers.

What Are the Ethical and Privacy Challenges Facing Medical Information Today?

Despite the undeniable benefits of digital medical information, significant concerns about data privacy and security persist. The rise of cyber-attacks and data breaches has left both patients and healthcare providers vulnerable to the potential misuse of sensitive medical information. One of the most pressing ethical issues involves the balance between data sharing and patient confidentiality. As more data is shared across networks to facilitate collaborative care and research, there is a growing need to ensure that patient consent is properly obtained, and their data remains secure. Regulatory frameworks, such as the Health Insurance Portability and Accountability Act (HIPAA) in the U.S. and the General Data Protection Regulation (GDPR) in Europe, have set strict guidelines on how medical data should be handled. However, these regulations vary significantly across regions, making it difficult to create a global standard for medical information security. Additionally, the use of artificial intelligence (AI) and machine learning algorithms to analyze medical data has sparked debates about potential biases in decision-making and the transparency of these systems. As technology continues to evolve, addressing these ethical and privacy challenges will be paramount to maintaining trust in the healthcare system.

What Role Does Technology Play in Transforming Access to Medical Information?

Technology is at the forefront of revolutionizing how medical information is accessed, shared, and utilized. The rise of big data analytics has enabled healthcare providers to analyze vast amounts of medical data to detect patterns and predict health outcomes, thus improving the overall efficiency of the healthcare system. The integration of cloud computing has further enabled healthcare organizations to store and access medical records securely while reducing the costs associated with on-premise storage systems. Furthermore, telemedicine platforms and patient portals have empowered patients to take more control of their health, allowing them to access their medical records, communicate with their healthcare providers, and even schedule appointments online. The use of AI in diagnostic tools is also enhancing the accuracy and speed of diagnosis, reducing the chances of human error and enabling healthcare providers to make more informed decisions. Wearable devices, such as smartwatches and fitness trackers, are allowing for continuous monitoring of patients’ vital signs, leading to early detection of health issues and more timely interventions. As the healthcare system continues to digitize, technology will undoubtedly play an even greater role in improving both the accessibility and quality of medical information.

What Are the Growth Drivers in the Medical Information Market?

The growth in the medical information market is driven by several factors, many of which are directly linked to technological advancements and changing consumer behavior. First, the increasing adoption of EHR systems across healthcare facilities worldwide has created a massive demand for reliable and scalable digital solutions. The need for interoperability between different systems is another key driver, as healthcare providers seek seamless ways to share patient information across multiple platforms and institutions. Additionally, the growing prevalence of chronic diseases has necessitated more frequent and comprehensive patient monitoring, leading to a surge in demand for remote monitoring devices and mHealth applications. Consumer behavior has also shifted, with patients increasingly expecting more convenient, digital-first healthcare experiences. This has driven the rapid growth of telemedicine services. Government initiatives promoting digital health and the need for data-driven decision-making in healthcare are also contributing to the expansion of the market. Lastly, the integration of AI and machine learning into medical information systems is enhancing predictive analytics and diagnostic accuracy, further fueling market growth by providing healthcare providers with cutting-edge tools to manage patient data more effectively.

Select Competitors (Total 36 Featured) -

  • Accenture Plc
  • Cognizant Technology Solutions U.S. Corporation
  • Eversana
  • Groupe ProductLife S.A.S.
  • Infosys Ltd.
  • Inizio Engage
  • Intellectsoft
  • IQVIA, Inc.
  • McKesson Corporation
  • Med Communications

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Medical Information - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Accurate and Timely Healthcare Data Propels Growth in the Medical Information Market
    • Increasing Focus on Patient-Centered Care Expands Addressable Market for Personalized Medical Information Solutions
    • Technological Advancements in Electronic Health Records (EHR) Drive Innovation in Medical Information Systems
    • Growing Use of AI and Machine Learning in Data Analysis Strengthens the Business Case for Medical Information Management
    • Rising Adoption of Telemedicine and Digital Health Platforms Spurs Demand for Real-Time Medical Information Access
    • Increasing Use of Mobile Health (mHealth) Apps Propels Growth in Consumer Access to Medical Information
    • Innovations in Blockchain for Secure Data Sharing Drive Trust in Medical Information Platforms
    • Here's How the Expansion of Health Information Exchanges (HIEs) Accelerates the Interoperability of Medical Information Systems
    • Surging Demand for Clinical Decision Support Systems (CDSS) Drives Growth in Medical Information Integration
    • Advancements in Wearable Devices and IoT Propel Growth in the Real-Time Medical Information Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Medical Information Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Medical Information by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Medical Information by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for In-House Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for In-House Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for In-House Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Contract Outsourcing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Contract Outsourcing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Contract Outsourcing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Pharmaceuticals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Medical Device Manufacturers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Medical Device Manufacturers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Medical Device Manufacturers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Biotechnology Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • JAPAN
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • CHINA
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • EUROPE
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Medical Information by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Medical Information by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • FRANCE
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • GERMANY
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Medical Information by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • INDIA
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Medical Information by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Medical Information by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Medical Information by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Medical Information by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030
  • AFRICA
    • Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Medical Information by Service Type - In-House Services and Contract Outsourcing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Medical Information by Service Type - In-House Services and Contract Outsourcing Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Medical Information by Service Type - Percentage Breakdown of Value Sales for In-House Services and Contract Outsourcing Services for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Medical Information by End-Use - Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Medical Information by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals End-Use, Medical Device Manufacturers End-Use and Biotechnology Companies End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제